Results 261 to 270 of about 594,568 (282)
Some of the next articles are maybe not open access.

Characterization of Single-Domain Antibodies with an Engineered Disulfide Bond

2012
Camelidae single-domain antibodies (VHHs) represent a unique class of emerging therapeutics. Similar to other recombinant antibody fragments (e.g., Fabs, scFvs), VHHs are amenable to library screening and selection, but benefit from superior intrinsic biophysical properties such as high refolding efficiency, high solubility, no tendency for aggregation,
Hussack, G., MacKenzie, C.R., Tanha, J.
openaire   +3 more sources

Single domain antibodies

2006
Classical antibodies are complex assemblies, difficult to produce in bacteria, and too bulky for many medical or research applications. Therefore, substantial efforts aimed at finding simpler miniaturised antibodies. Heavy-chain antibodies in camelids are a natural source of such mini-antibodies. Moreover, their antigen-binding domain (named Nanobody),
openaire   +1 more source

[Progress in shark single-domain antibody].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2020
Monoclonal antibody (mAb) is an important biological macromolecule and widely used in immune detection, in vitro diagnostics, and drug discovery. However, the inherent properties of mAb restrict its further development, such as high molecular weight and complex structure. Therefore, there is an urgent need to develop alternatives for mAb. Various types
Xing, Liu, Qi, Chen
openaire   +1 more source

Identification of Human Single-Domain Antibodies against SARS-CoV-2

Cell Host and Microbe, 2020
Yanling Wu, Cheng Li, Shuai Xia
exaly  

Development of a platform process for the production and purification of single‐domain antibodies

Biotechnology and Bioengineering, 2021
Laura E Crowell   +2 more
exaly  

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors

EMBO Molecular Medicine, 2020
Elena Barbon   +2 more
exaly  

SINGLE DOMAIN ANTIBODIES

The Lancet, 1989
openaire   +1 more source

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Cell Host and Microbe, 2021
Gabriele Cerutti   +2 more
exaly  

Home - About - Disclaimer - Privacy